Wei Guo

机构：Xuzhou Medical College, Qilu Hospital of Shandong University · ORCID：0000-0002-1801-6081

发表论文 10 篇 · 总被引 88 次 · h-index 6

代表论文

• PD ‐1: A critical player and target for immune normalization (2024 · Immunology · 被引 20)
• PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma (2024 · International Immunopharmacology · 被引 18)
• FTY720 Modulating Microglia-Mediated Cholesterol Recycling via TREM2 Promotes Remyelination Following Ischemic Damage (2025 · Stroke · 被引 12)
• Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study (2024 · Acta Pharmaceutica Sinica B · 被引 10)
• Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions (2023 · iRadiology · 被引 8)
• Dual Targeting of Integrin αvβ3 and Neuropilin-1 Receptors Improves Micropositron Emission Tomography Imaging of Breast Cancer (2022 · Molecular Pharmaceutics · 被引 8)